VYNE Therapeutics Inc. deeply regrets to announced that Mr. Rex Bright passed away on January 11, 2022. Mr. Bright was a director of the company and also served as the Chair of the Company's Compensation Committee and a member of the Company's Audit Committee. On January 14, 2022, the Board appointed Patrick LePore to serve as a member of the Company's Audit Committee and Elisabeth Sandoval to serve as chairperson of the Compensation Committee.